View of Putting Patients First: How the FDA Could Use Its Existing Powers to Reduce Post-Market Adverse Events

Return to Article Details Putting Patients First: How the FDA Could Use Its Existing Powers to Reduce Post-Market Adverse Events Download Download PDF